Infectious Diseases Section, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Infectious Diseases, Department of Internal Medicine I, Tübingen University Hospital, Tübingen, Germany.
J Antimicrob Chemother. 2020 Dec 6;75(Suppl 2):ii42-ii51. doi: 10.1093/jac/dkaa428.
The outpatient setting is a key scenario for the implementation of antimicrobial stewardship (AMS) activities, considering that overconsumption of antibiotics occurs mainly outside hospitals. This publication is the result of a joint initiative by the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks, which is aimed at formulating a set of target actions for linking surveillance data with AMS activities in the outpatient setting.
A scoping review of the literature was carried out in three research areas: AMS leadership and accountability; antimicrobial usage and AMS; antimicrobial resistance and AMS. Consensus on the actions was reached through a RAND-modified Delphi process involving over 40 experts in infectious diseases, clinical microbiology, AMS, veterinary medicine or public health, from 18 low-, middle- and high-income countries.
Evidence was retrieved from 38 documents, and an initial 25 target actions were proposed, differentiating between essential or desirable targets according to clinical relevance, feasibility and applicability to settings and resources. In the first consultation round, preliminary agreement was reached for all targets. Further to a second review, 6 statements were re-considered and 3 were deleted, leading to a final list of 22 target actions in the form of a practical checklist.
This White Paper is a pragmatic and flexible tool to guide the development of calibrated surveillance-based AMS interventions specific to the outpatient setting, which is characterized by substantial inter- and intra-country variability in the organization of healthcare structures, maintaining a global perspective and taking into account the feasibility of the target actions in low-resource settings.
鉴于抗生素的过度使用主要发生在医院之外,门诊环境是实施抗菌药物管理(AMS)活动的关键场景。本出版物是 JPIAMR ARCH 和 COMBACTE-MAGNET EPI-Net 网络的联合倡议的结果,旨在制定一系列将监测数据与门诊环境中的 AMS 活动联系起来的目标行动。
在三个研究领域进行了文献范围的综述:AMS 领导和问责制;抗菌药物使用与 AMS;抗菌药物耐药性与 AMS。通过涉及来自 18 个低收入、中等收入和高收入国家的 40 多名传染病、临床微生物学、AMS、兽医或公共卫生专家的 RAND 改良 Delphi 过程,就行动达成了共识。
从 38 份文件中检索到证据,并提出了最初的 25 个目标行动,根据临床相关性、可行性和对环境和资源的适用性,将目标行动分为基本或理想目标。在第一轮咨询中,所有目标都初步达成一致。在第二轮审查后,重新考虑了 6 项声明并删除了 3 项声明,最终形成了一份 22 项目标行动的实用清单。
本白皮书是指导制定针对门诊环境的基于监测的 AMS 干预措施的实用且灵活的工具,门诊环境在医疗结构的组织方面存在很大的国家间和国家内差异,保持全球视角并考虑到在资源有限的环境中实施目标行动的可行性。